← Acquirers
Acquirer profileAustralia

Who is ALS Limited?

ALS Limited is a private equity firm based in Australia.

ALS Limited logo
Firm facts

ALS Limited

Type
private equity firm
Headquarters
Australia
Last verified 2026-10-24
Has ALS Limited approached you? Here’s what to do.

How they work

ALS Limited (ASX: ALQ) is an Australian global testing, inspection and analytical services group serving commodities, environmental, food and pharmaceutical markets. It reported FY26 revenue of A$3.32 billion; its corporate overview reports operations across 70+ countries, 450+ offices and 22,000+ staff.

ALS publishes no formal seller-facing acquisition process or target submission channel. Its public results describe disciplined capital allocation, targeted growth investment and portfolio optimisation; its releases document completed acquisitions and subsequent integration. Its investor page lists shareholder enquiries, not an M&A contact, so the correct transaction contact is not publicly specified.

Sector focus
ALS focuses on testing, inspection and analytical services across Commodities and Life Sciences, including environmental, food, pharmaceutical and industrial-materials testing. Public strategy stresses extending testing capabilities and geographic reach through disciplined growth investment and acquisitions.

Their portfolio

Showing 5 of 5 known holdings — coverage is still partial.

  • Algoritmos y Mediciones Ambientales SpA
    SectorProfessional & business services
    What they doAcquired December 2023. This Chilean environmental-services company performs environmental monitoring and analysis. ALS’s FY26 annual report lists the legal entity as a 100%-owned controlled entity at 31 March 2026; its official operating website remains active.
  • ALS Germany GmbH (formerly WESSLING GmbH) and retained Wessling testing operations
    SectorProfessional & business services
    What they doALS completed its acquisition of Wessling Holding GmbH & Co. KG in June 2024 (100%). The acquired testing businesses operated across environmental, pharmaceutical and food analysis, with about 1,200 staff across four European countries. WESSLING GmbH became ALS Germany GmbH from October 2025; FY26 reporting confirms integration of retained testing operations. ALS sold WESSLING Consulting Engineering (WCE) and IFUA in December 2025, so those divested consulting businesses are excluded. The former official Wessling domain now redirects to ALS Germany.
  • SectorProfessional & business services
    What they doAcquired February 2023. EHC provides environmental and occupational-health studies, industrial hygiene and toxicology testing. ALS’s FY26 annual-report entity schedule lists the Romanian company as 100%-owned; the official ALS acquisition page links to EHC’s operating website.
  • Nuvisan (Nuvisan GmbH and Nuvisan ICB GmbH)
    SectorProfessional & business services
    What they doOn 25 March 2024, ALS announced an agreement to acquire the remaining 51% of Nuvisan for €1. The transaction was effective for financial reporting/control purposes on 31 March 2024, with trading results included from 1 April 2024, taking ALS to 100% ownership. Nuvisan provides pharmaceutical testing and contract research services in Germany and France; FY26 reporting says third-party revenue continued to grow and its transformation program was completed.
  • York Analytical Laboratories, Inc.
    SectorProfessional & business services
    What they doALS FY25 reporting says it acquired 100% of York Analytical Laboratories, Inc. in April 2024. York is a Northeast US environmental testing laboratory with eight locations, specializing in water, soil, air and regulated-contaminant testing including PFAS. ALS’s FY26 results still discuss York integration challenges, confirming ongoing operations. The former York domain says it joined ALS in March 2024, while the annual report dates the acquisition to April; the disclosed ~A$35 million is York calendar-2023 revenue, not deal value.
Want updates related to acquisitions?

Sources

The truth, first.Data as at 2026-10-24
GET IN TOUCH

Let's talk.

Choose the conversation you need. We'll come back to you with next steps.

Free, confidential discussion

Talk through an approach, buyer fit, or what may drive your business’s value. We’ll reply to arrange a time.

What do you need?

This request does not subscribe you to the newsletter.